课题基金 / 基金详情

阿尔茨海默病Aβ生成中apelin/APJ系统的调控作用与干预机制研究

批准号:
81971019
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
吴伊丽
依托单位:
学科分类:
意识障碍与认知功能障碍
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
吴伊丽

项目摘要

结项摘要

项目成果

吴伊丽的其他基金

相似基金

相关文献

中文摘要
Aβ过度生成是阿尔茨海默病(AD)发生的关键机制,导致β淀粉样斑块形成和认知障碍。内质网应激激活的未折叠蛋白反应(UPR)促进Aβ生成。我们研究显示apelin/APJ系统抑制UPR,但apelin/APJ对Aβ生成的作用还不清楚。Aβ前体蛋白经BACE1和γ-分泌酶剪切生成Aβ,TMP21是γ-分泌酶的调节因子。UPR上调BACE1表达,而BACE1升高和TMP21降低促进Aβ生成。我们预实验显示apelin/APJ在AD中显著下调,而apelin/APJ干预可缓解UPR及BACE1和TMP21的异常调控,降低Aβ生成。据此提出科学假设:apelin/APJ通过缓解UPR介导的BACE1和TMP21异常调控而抑制Aβ生成。我们将以apein/APJ对Aβ生成的作用为切入点,明确apein/APJ对Aβ生成的调控作用和机制及对β淀粉样斑块形成和认知障碍的影响,为AD治疗提供新策略。
英文摘要
Increased Aβ generation is the major cause of the pathogenesis of Alzheimer’s disease(AD), resulting in amyloid plaque formation and cognitive deficits. Endoplasmic reticulum stress(ERS)-activated unfolded protein response (UPR)promotes Aβ generation. Our previous studies showed that apelin/APJ attenuates UPR. However, the role of apelin/APJ in Aβ generation remains elusive. Aβ is generated from Aβ precursor protein by sequential cleavages of BACE1 and γ-secretase, while TMP21 is a regulator of γ-secretase. UPR increases BACE1 expression, while increased BACE1 and reduced TMP21 promote Aβ generation. Our preliminary data showed that apelin/APJ attenuates UPR and the dysregulation of BACE1 and TMP21 in AD, and reduces Aβ generation. Thus, we proposed that apelin/APJ inhibits Aβ generation by attenuating UPR-mediated dysregulation of BACE1 and TMP21. We plan to further determine the role of apelin/APJ in Aβ generation, amyloid plaque formation and cognitive deficits in AD, and elucidate the underlying mechanisms. This study will provide a novel strategy for AD treatment.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Gender Difference in Associations Between Telomere Length and Risk Factors in Patients With Stroke.
中风患者端粒长度与危险因素之间关联的性别差异。
DOI: 10.3389/fnagi.2021.719538
发表时间: 2021
期刊: Frontiers in aging neuroscience
影响因子: 4.8
作者: [Wang Y, Jiao F, Zheng H, Kong Q, Li R, Zhang X, Yan L, Hao Y, Wu Y]
通讯作者: Wu Y
DOI: 10.3233/jad-221184
发表时间: 2023-03
期刊: Journal of Alzheimer's disease : JAD
影响因子: --
作者: [Ran Li;Beibei Song;Lu Xu;Jianguo Zheng;Wenhao Pan;Fang Cai;Juelu Wang;Yili Wu;Weihong Song]
通讯作者: Ran Li;Beibei Song;Lu Xu;Jianguo Zheng;Wenhao Pan;Fang Cai;Juelu Wang;Yili Wu;Weihong Song
DOI: 10.1038/s41392-022-01157-x
发表时间: 2022
期刊: Signal Transduction and Targeted Therapy
影响因子: 39.3
作者: [Xi Liu, Rongbo Che, Wenping Lang, Yun Zhang, Liyong Wu, Chao Han, Hong Lu, Weihong Song, Yili Wu, Zhe Wang]
通讯作者: Zhe Wang
BACE2 degradation is mediated by both the proteasome and lysosome pathways
BACE2 降解由蛋白酶体和溶酶体途径介导
DOI: 10.1186/s12860-020-00260-7
发表时间: 2020-03
期刊: BMC Molecular and Cell Biology
影响因子: 2.8
作者: [Kaixin Qiu, Wenping Liang, Shuai Wang, Tingting Kong, Xin Wang, Chunyan Li, Zhe Wang, Yili Wu]
通讯作者: Yili Wu
共 6 条
    阿尔茨海默病中RCAN1对BACE2的β-分泌酶活性的调控作用和机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      51万元
    • 批准年份:
      2022
    • 负责人:
      吴伊丽
    • 依托单位:
    国内基金
    海外基金